US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist
  • 129.870
  • -0.770-0.59%
Close Dec 13 16:00 ET
  • 129.870
  • 0.0000.00%
Post 20:01 ET
7.76BMarket Cap-16.63P/E (TTM)

Ascendis Pharma A/S Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
20.40%57.83M
-24.04%36M
185.49%95.89M
421.20%266.72M
501.42%137.7M
214.15%48.03M
669.37%47.39M
391.93%33.59M
557.93%51.17M
367.55%22.9M
Operating revenue
20.40%57.83M
-1.33%36M
185.49%95.89M
421.20%266.72M
501.42%137.7M
214.15%48.03M
492.27%36.48M
391.93%33.59M
557.93%51.17M
367.55%22.9M
Cost of revenue
51.61%11.2M
-11.32%11.47M
63.80%7.57M
265.78%44.4M
280.61%19.46M
336.39%7.39M
1,090.52%12.93M
8.83%4.62M
244.51%12.14M
45.10%5.11M
Gross profit
14.73%46.63M
-28.82%24.53M
204.91%88.33M
469.52%222.32M
564.90%118.25M
198.93%40.65M
579.23%34.46M
1,021.92%28.97M
817.44%39.04M
1,194.32%17.78M
Operating expense
-18.10%143.38M
-9.99%157.79M
-20.38%137.47M
12.82%677.86M
-6.24%154.86M
10.72%175.05M
19.28%175.3M
32.19%172.65M
31.75%600.85M
44.94%165.17M
Selling and administrative expenses
8.98%68.13M
2.87%72.3M
0.37%66.78M
19.52%264.41M
19.80%67.75M
3.04%62.51M
24.21%70.28M
40.32%66.54M
38.11%221.23M
17.08%56.55M
-General and administrative expense
8.98%68.13M
--72.3M
----
----
----
--62.51M
----
----
----
----
Research and development costs
-34.01%73.54M
-20.51%83.48M
-33.39%70.69M
8.91%413.45M
-16.33%90.88M
14.38%111.44M
16.20%105.02M
27.55%106.11M
28.31%379.62M
65.45%108.62M
Depreciation amortization depletion
54.59%1.7M
--2.02M
----
----
----
--1.1M
----
----
----
----
-Depreciation and amortization
54.59%1.7M
--2.02M
----
----
----
--1.1M
----
----
----
----
Operating profit
28.02%-96.74M
5.38%-133.26M
65.80%-49.15M
18.92%-455.54M
75.16%-36.61M
6.99%-134.41M
0.74%-140.84M
-12.23%-143.69M
-24.35%-561.81M
-30.92%-147.39M
Net non-operating interest income expense
114.39%2.93M
11.36%29.43M
-308.49%-73.59M
-16.99%-27.21M
4.35%-68.55M
2.60%-20.38M
-57.16%26.43M
361.67%35.3M
-622.46%-23.26M
-58.47%-71.67M
Non-operating interest income
582.74%28.28M
37.17%49.05M
-92.08%3.58M
127.00%16.86M
9.41%-60.13M
-79.62%4.14M
-49.72%35.76M
246.02%45.14M
973.12%7.43M
-51.20%-66.37M
Non-operating interest expense
3.38%25.35M
110.24%19.62M
684.16%77.16M
43.62%44.07M
58.93%8.43M
-40.56%24.52M
-1.06%9.33M
82.26%9.84M
684.51%30.68M
298.27%5.3M
Other net income (expense)
35.72%-4.37M
28.57%-5.32M
-372.37%-5.8M
18.64%8.61M
41.72%24.08M
-83.82%-6.79M
-539.02%-7.45M
74.82%-1.23M
-89.79%7.25M
-67.10%16.99M
Gain on sale of security
----
----
----
8.22%27M
----
----
----
----
-57.73%24.95M
----
Earnings from equity interest
35.72%-4.37M
28.57%-5.32M
-372.37%-5.8M
-3.94%-18.4M
63.27%-2.92M
-83.82%-6.79M
-539.02%-7.45M
74.82%-1.23M
-246.97%-17.7M
-7.68%-7.96M
Income before tax
39.24%-98.18M
10.43%-109.15M
-17.25%-128.53M
17.94%-474.14M
59.87%-81.09M
4.46%-161.58M
-49.77%-121.86M
12.49%-109.62M
-50.50%-577.82M
-90.32%-202.07M
Income tax
58.14%1.02M
153.38%229K
93.37%2.51M
35.82%7.3M
8.24%5.79M
486.23%645K
-812.77%-429K
438.17%1.3M
1,565.12%5.38M
4,792.11%5.35M
Net income
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
Net income continuous Operations
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
Minority interest income
Net income attributable to the parent company
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.85%-99.2M
9.93%-109.38M
-18.14%-131.04M
17.45%-481.45M
58.11%-86.88M
3.98%-162.22M
-49.33%-121.43M
11.62%-110.91M
-52.04%-583.19M
-95.56%-207.42M
Basic earnings per share
40.28%-1.72
11.57%-1.91
-16.16%-2.3
17.79%-8.55
58.38%-1.54
4.95%-2.88
-47.95%-2.16
10.41%-1.98
-48.57%-10.4
-97.86%-3.7
Diluted earnings per share
40.28%-1.72
11.57%-1.91
-16.16%-2.3
17.79%-8.55
58.38%-1.54
4.95%-2.88
-47.95%-2.16
10.41%-1.98
-48.57%-10.4
-97.86%-3.7
Dividend per share
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 20.40%57.83M-24.04%36M185.49%95.89M421.20%266.72M501.42%137.7M214.15%48.03M669.37%47.39M391.93%33.59M557.93%51.17M367.55%22.9M
Operating revenue 20.40%57.83M-1.33%36M185.49%95.89M421.20%266.72M501.42%137.7M214.15%48.03M492.27%36.48M391.93%33.59M557.93%51.17M367.55%22.9M
Cost of revenue 51.61%11.2M-11.32%11.47M63.80%7.57M265.78%44.4M280.61%19.46M336.39%7.39M1,090.52%12.93M8.83%4.62M244.51%12.14M45.10%5.11M
Gross profit 14.73%46.63M-28.82%24.53M204.91%88.33M469.52%222.32M564.90%118.25M198.93%40.65M579.23%34.46M1,021.92%28.97M817.44%39.04M1,194.32%17.78M
Operating expense -18.10%143.38M-9.99%157.79M-20.38%137.47M12.82%677.86M-6.24%154.86M10.72%175.05M19.28%175.3M32.19%172.65M31.75%600.85M44.94%165.17M
Selling and administrative expenses 8.98%68.13M2.87%72.3M0.37%66.78M19.52%264.41M19.80%67.75M3.04%62.51M24.21%70.28M40.32%66.54M38.11%221.23M17.08%56.55M
-General and administrative expense 8.98%68.13M--72.3M--------------62.51M----------------
Research and development costs -34.01%73.54M-20.51%83.48M-33.39%70.69M8.91%413.45M-16.33%90.88M14.38%111.44M16.20%105.02M27.55%106.11M28.31%379.62M65.45%108.62M
Depreciation amortization depletion 54.59%1.7M--2.02M--------------1.1M----------------
-Depreciation and amortization 54.59%1.7M--2.02M--------------1.1M----------------
Operating profit 28.02%-96.74M5.38%-133.26M65.80%-49.15M18.92%-455.54M75.16%-36.61M6.99%-134.41M0.74%-140.84M-12.23%-143.69M-24.35%-561.81M-30.92%-147.39M
Net non-operating interest income expense 114.39%2.93M11.36%29.43M-308.49%-73.59M-16.99%-27.21M4.35%-68.55M2.60%-20.38M-57.16%26.43M361.67%35.3M-622.46%-23.26M-58.47%-71.67M
Non-operating interest income 582.74%28.28M37.17%49.05M-92.08%3.58M127.00%16.86M9.41%-60.13M-79.62%4.14M-49.72%35.76M246.02%45.14M973.12%7.43M-51.20%-66.37M
Non-operating interest expense 3.38%25.35M110.24%19.62M684.16%77.16M43.62%44.07M58.93%8.43M-40.56%24.52M-1.06%9.33M82.26%9.84M684.51%30.68M298.27%5.3M
Other net income (expense) 35.72%-4.37M28.57%-5.32M-372.37%-5.8M18.64%8.61M41.72%24.08M-83.82%-6.79M-539.02%-7.45M74.82%-1.23M-89.79%7.25M-67.10%16.99M
Gain on sale of security ------------8.22%27M-----------------57.73%24.95M----
Earnings from equity interest 35.72%-4.37M28.57%-5.32M-372.37%-5.8M-3.94%-18.4M63.27%-2.92M-83.82%-6.79M-539.02%-7.45M74.82%-1.23M-246.97%-17.7M-7.68%-7.96M
Income before tax 39.24%-98.18M10.43%-109.15M-17.25%-128.53M17.94%-474.14M59.87%-81.09M4.46%-161.58M-49.77%-121.86M12.49%-109.62M-50.50%-577.82M-90.32%-202.07M
Income tax 58.14%1.02M153.38%229K93.37%2.51M35.82%7.3M8.24%5.79M486.23%645K-812.77%-429K438.17%1.3M1,565.12%5.38M4,792.11%5.35M
Net income 38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M
Net income continuous Operations 38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M
Minority interest income
Net income attributable to the parent company 38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.85%-99.2M9.93%-109.38M-18.14%-131.04M17.45%-481.45M58.11%-86.88M3.98%-162.22M-49.33%-121.43M11.62%-110.91M-52.04%-583.19M-95.56%-207.42M
Basic earnings per share 40.28%-1.7211.57%-1.91-16.16%-2.317.79%-8.5558.38%-1.544.95%-2.88-47.95%-2.1610.41%-1.98-48.57%-10.4-97.86%-3.7
Diluted earnings per share 40.28%-1.7211.57%-1.91-16.16%-2.317.79%-8.5558.38%-1.544.95%-2.88-47.95%-2.1610.41%-1.98-48.57%-10.4-97.86%-3.7
Dividend per share
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.